General form of registration statement for all companies including face-amount certificate companies

Note 5 - Cash, Cash Equivalents and Investments (Details Textual)

v3.24.4
Note 5 - Cash, Cash Equivalents and Investments (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Pieris Pharmaceuticals, Inc. [Member]            
Debt Securities, Available-for-Sale, Realized Gain (Loss) $ 0 $ 0 $ 0 $ (100) $ (100) $ 400